Capital Fund Management (CFM)
GHDX

Capital Fund Management (CFM)’s Genomic Health, Inc. GHDX Stock Holding History

Capital Fund Management (CFM)’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,100
Closed -$820K – 1998
2019
Q2 		$820K Buy
14,100
+9,000
+176% +$533K 0.01% 1076
2019
Q1 		$357K Buy
5,100
+1,500
+42% +$111K ﹤0.01% 1381
2018
Q4 		$232K Buy
+3,600
New +$252K ﹤0.01% 1704
2015
Q4 		– Sell
-11,900
Closed -$252K – 1802
2015
Q3 		$252K Buy
+11,900
New +$307K ﹤0.01% 1264
2014
Q1 		– Sell
-16,000
Closed -$468K – 2047
2013
Q4 		$468K Buy
+16,000
New +$508K 0.01% 1282

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Capital Fund Management (CFM)'s GHDX Position: Q3 2019 in Review

Capital Fund Management (CFM) sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 14,100 shares — an estimated $820K sold.

Capital Fund Management (CFM) first reported a position in GHDX in Q4 2013 and held it in 5 quarters. The position peaked at $820K in Q2 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Capital Fund Management (CFM) reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 14,100 Genomic Health, Inc. shares in Q3 2019, an estimated $820K.
  • Capital Fund Management (CFM) first reported a position in Genomic Health, Inc. in Q4 2013 and held it in 5 quarters.
  • Capital Fund Management (CFM)'s Genomic Health, Inc. position peaked at $820K in Q2 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2019, filed 13 Nov 2019.